Maynard Um
-
-
-
-
-
-
-
Goldman Sachs Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral
-
-
-
-
-
-
-
BioMarin appoints Ian Clark as board chair, Richard Meier to retire
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Misses Q4 EPS by 31c; offers guidance
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) discontinues development of BMN 349
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $55 at H.C. Wainwright
-
-
-
-
-
-
-
Why public perception matters so much for biotech valuations
-
406,345 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

